5 insiders reported 6 Form 4 transactions for Indaptus Therapeutics, Inc. (INDP) over the past 18 months (most recent 2026-01-22). Recent activity: Ben-Tzvi Avraham (Director) Buy 25,000 shares, Meckler Jeffrey A (Co-Chief Executive Officer) Buy 216,617 shares, Sassi Nir (Chief Financial Officer) Buy 26,758 shares, Linscott Walt Addison (Chief Operating Officer) Buy 54,421 shares, Newman Michael James (CSO and Director) Buy 52,204 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-22 | Ben-Tzvi Avraham | Director | Buy | 25,000 | $0 |
| 2025-12-29 | Meckler Jeffrey A | Co-Chief Executive Officer | Buy | 216,617 | $439,733 |
| 2025-12-29 | Sassi Nir | Chief Financial Officer | Buy | 26,758 | $54,319 |
| 2025-12-29 | Linscott Walt Addison | Chief Operating Officer | Buy | 54,421 | $110,475 |
| 2025-12-29 | Newman Michael James | CSO and Director | Buy | 52,204 | $105,974 |
| 2025-07-29 | Meckler Jeffrey A | Chief Executive Officer | Buy | 6,068 | $50,364 |
Source: SEC Form 4 filings · as of 2026-01-22